Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric ParticipantsBusiness Wire • 03/09/22
Most Side Effects From Pfizer, Moderna Covid Shots Are Mild And Short-Lived, Major Study FindsForbes • 03/08/22
Pfizer Inc. (PFE) Management Presents at Cowen 42nd Annual Health Care Conference (Transcript)Seeking Alpha • 03/07/22
What's next for Pfizer, Moderna beyond their projected $51 billion in combined Covid vaccine sales this yearCNBC • 03/03/22
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus (RSV) Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant WomenBusiness Wire • 03/02/22
Jeff Reeves's Strength in Numbers: Haul away these 10 bargains in beaten-down quality stocks before it's too lateMarket Watch • 03/01/22
Phase 3 CLOVER Trial for Pfizer's Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary EndpointsBusiness Wire • 03/01/22
Pfizer/BioNTech vaccine found to be much less affective in preventing infection in children aged 5 to 11: NYTMarket Watch • 03/01/22
Pfizer COVID-19 vaccine may be less effective in young children ages 5-11, new data showsBusiness Insider • 03/01/22
Pfizer Covid vaccine was just 12% effective against omicron in kids 5 to 11, study findsCNBC • 02/28/22